Pick a time period -
No more available filters You need to apply a filter before selecting newsroom

Use our filters to get your customized news. Save and subscribe to as many filters as you want, get the news that YOU are interested in right in your mailbox, RSS feed or in your personalized dashboard. Share your stories, news, multimedia and pressreleases and get a wider audience with news.cision.com.

Axactor Group acquires large portfolio of consumer claims in Italy

Oslo, 6th December 2018 Axactor has acquired another significant portfolio of unsecured consumer claims from a large financial institution in Italy. The acquisition is the second portfolio from this seller after the team acquired their last portfolio at the end of 2017. The portfolio has an outstanding balance of approximately 70 mEUR, across 10.000 cases. Endre Rangnes, CEO Axactor Group, commented “This acquisition is another significant investment for Axactor Group in Italy and comes from a seller we have worked with before. The team continue to work on several other important

Carnegie continues to win customer approval

- Top placed again for Nordic corporate actions!Carnegie continues to improve its customer approval in the Nordic market. The investment bank had once again topped the ranking of corporate transaction advisors. This was according to the Kantar Sifo Prospera customer survey, published on Thursday.For the third consecutive year, Carnegie is the most valued advisor in the Nordic market for corporate transactions, both overall and for equity capital markets (ECM) transactions. At the same time, Carnegie maintains a leading position in mergers and acquisitions (M&As), according to the latest

Correction of ÖstVäst Advisory AB’s shareholding in Nexam Chemical Holding AB (publ)

ÖstVäst Advisory AB’s correct shareholding in Nexam Chemical Holding AB (publ) as per December 5 is 2.987.973 shares, this represents 4,425 percent of the total amount of shares in the Company. In an earlier press release dated December 5, where it was notified that ÖstVäst Advisory AB will be represented in the nomination committee of Nexam Chemical Holding AB (publ), the shareholding was incorrectly specified to be about 3 percent. This incorrect figure is hereby corrected.Note: This press release has been translated from Swedish. The Swedish text shall govern for all purposes and prevail

IX Australia deploys Smartoptics’ low cost 100G Open Line System

Oslo, Norge – 6 December 2018 – Smartoptics, a leading provider of open optical networking solutions, today announced that the Internet Exchange Australia (IX Australia) has deployed Smartoptic s DCP-M40 Open Line System  and Pluggable DWDM QSFP28 PAM4 Transceivers to provide high capacity links between IX Australia’s metro locations in Sydney. The new, automated, network was delivered by Independent Data Solutions (IDS) and provides IX Australia with lowest cost 40 x 100 Gb/s traffic capability over a single pair

Divestment of rights to Covis completed

6 December 2018 07:00 GMT Divestment of rights to Alvesco, Omnaris  and Zetonna to Covis Pharma completed    AstraZeneca has completed an agreement with Covis Pharma B.V. (Covis Pharma) to sell its rights to the medicines Alvesco (ciclesonide), used for the treatment of persistent asthma, and Omnaris and Zetonna(ciclesonide), used for the treatment of nasal symptoms associated with rhinitis. The rights cover markets outside the US and the US royalties for the medicines. The transaction does not include the transfer of any AstraZeneca employees or facilities. Under the terms of

FOSSID establishes first independent mirror of world’s largest source code archive

FOSSID mirrors Software Heritage’s growing source code archive of 5 billon source code files, enabling continuous access to digital informationStockholm, Sweden, and Paris, France, December 6, 2018 - FOSSID and Software Heritage today announced that they have signed an agreement to establish the first independent mirror of the largest source code archive in the world. 5 Billion source code files and growingSoftware Heritage collects, preserves, and shares software code (both freely and not freely licensed) in a universal software storage archive. FOSSID helps secure the archive in an

Golden Heights announces that SEB has been mandated to explore refinancing alternatives for the 2014/2019 bond

Golden Heights AB (publ) has mandated SEB to explore refinancing alternatives for the 2014/2019 bond in the capital markets early 2019. For further information, please contact: Madeléne Wingård, managing director, tel: +46 340 59 54 10. This information is information that Golden Heights AB (publ) is obliged to make public pursuant to the EU Market Abuse Regulation 596/2014/EU. The information was submitted for publication, through the agency of the contact persons above, on December 6th, 2018 at 08:00 CET.

The Qt Company Introduces Qt 5.12, the Latest Version of its Framework for the Creation of Fast, High-Quality Applications and User Interfaces

Qt Group Plc  Press release  6th December 2018Qt 5.12 Offers Long-Term Support and Higher Performance and Quality Than Ever Before Espoo, Finland – December 6, 2018 – The Qt Company  today introduced Qt 5.12 , the latest version of its cross-platform software development framework that enables developers to design and build fast, high-quality applications, user interfaces and embedded devices. In addition to long-term support (LTS), Qt 5.12 offers higher performance and quality than ever before, resulting in a comprehensive software

Diamyd Medical raises SEK 58.4 million in funds through redemption of warrants

During 1 to 30 November 2018, holders of warrants of series TO 1 B and TO 2 A of Diamyd Medical AB have been able to subscribe for shares through warrants. A total of 426 037 A shares and 12 409 855 B shares have been subscribed for, which means a subscription rate of 95.6 percent. Diamyd Medical thus raises approximately SEK 58.4 million before issue costs."We are delighted at the outcome of the redemption of warrants," says Ulf Hannelius, CEO of Diamyd Medical. “The proceeds, together with existing cash, will finance both the DIAGNODE-2 trial until results in 2020 as well as our other

Pre-submission meeting with EMA has been completed

As previously announced, Double Bond Pharmaceutical has submitted an application to EMA for scientific advice, known as Protocol Assistance, for SI-053. The Protocol Assistance is given based on questions to EMA that the company prepares in advance regarding the clinical trial protocol for their product, and the quality of these questions is crucial for the outcome of the meeting in the form of value for the company and for product development. Yesterday, Double Bond Pharmaceutical had therefore a pre-submission meeting with EMA and discussed the layout of these questions, before the

Autoliv Provides Update on European Commission Investigation and Announces $210 Million Accrual

(Stockholm, Sweden, December 6, 2018) – Autoliv, Inc. (NYSE: ALV and SSE: ALIVsdb), the worldwide leader in automotive safety systems, provides an update on the European Commission’s investigation of suppliers of occupant safety systems.As previously disclosed, since June 2011, Autoliv has been subject to an investigation of anti-competitive behavior among suppliers of occupant safety systems in the European Union (the “EC investigation”). Autoliv has been cooperating with the EC investigation. The EC previously concluded a discrete portion of its investigation in November 2017 and imposed

Lund University and PHI partner to develop novel 3D cell culturing methods for immunotherapy research

Based on PHI's current HoloMonitor technology, the Department of Immunotechnology at Lund University  and Phase Holographic Imaging (PHI) recently agreed to jointly develop novel 3-dimensional cell culturing methods to meet the urgent need for such methods. In a counter purchase agreement, PHI obtains onco­immuno­logical expertise and the right to market developed methods. By purchasing scientific instru­men­tation and software from PHI, the department obtains access to PHI's HoloMonitor technology.The toxins used when treating cancer with chemotherapy act by being

Royal Air Maroc to join oneworld

Royal Air Maroc is to join oneworld®, adding one of Africa’s leading and fastest growing airlines to the world’s premier airline alliance.  Royal Air Maroc is expected to be implemented into oneworld in mid-2020, when it will start flying alongside some of the biggest and best brands in the airline business. Its regional subsidiary Royal Air Maroc Express will join as a oneworld affiliate member at the same time.   Royal Air Maroc is today the largest unaligned carrier in Africa – with a transformational strategy well underway to develop it quickly into a truly global airline and the

SciBase announces skin barrier testing collaboration with leading Swiss research center

SciBase and Swiss Institute of Allergy and Asthma Research, Davos Switzerland (SIAF-SFI) announced today the signing of a formal collaboration agreement within the area of barrier function testing using Electrical Impedance Spectroscopy (EIS). In addition the partners have jointly filed a patent application covering the use of electrical impedance testing for the evaluation of epithelial barrier function, potentially a unique tool to help address some of the most common disorders such as eczema, food allergy, allergic rhinitis and asthma. The agreement formalises a research co-operation

Induct - Notice of updated agenda for extraordinary general meeting – proposal for private placement towards NPP Capital AS

Reference is made to the announcement from Induct AS (the "Company") on 29 November 2018 regarding a call for an extraordinary general meeting. Following such announcement, NPP Capital AS ("NPP") , a company 100% owned by Induct's CEO Alf Martin Johansen, has asked the board of directors to propose a separate private placement to NPP. Pursuant to such private placement, NPP may subscribe for 65 532 shares in the Company (which is based on a shareholding of NPP of 956,522 shares) with a corresponding number of warrants attached. Such private placement will allow NPP to participate in the

Orexo hosts Capital Markets Day today in Stockholm, Sweden

Uppsala, Sweden – December 6, 2018 – Orexo AB (publ.), the fully integrated specialty pharmaceutical company addressing opioid addiction and pain, is today hosting the Company’s  Capital Markets Day for investors, analysts and media in Stockholm, Sweden. Orexo’s management team will expand on new strategic initiatives building upon the Company’s strong financial and operational foundation, primarily driven by the performance for Zubsolv® in the US. The event will highlight the Company’s plans to further strengthen its pipeline and innovative formulation technologies. In addition,

Scania to supply 15 trucks for German e-highways

Scania is to supply vehicles for the three Germany e-highway in trials that are expected to start next year. The decision was taken on behalf of the German Federal Ministry for Environment, Nature Conservation and Nuclear Safety (BMU), following a public tender process.Trials will initially commence in Hessen along the A5 Autobahn, where the five-kilometre e-highway infrastructure with electric power supplied from overhead lines in both directions has been completed. Next will be an e-highway segment on the A1 Autobahn to the Port of Lübeck, with additional stationary charging capacity

Diabetes drug liraglutide linked to lower risk of cardiovascular events

[PRESS RELEASE 2018-12-06] Real world data from a large Nordic study shows that use of liraglutide, a drug for type 2 diabetes, is associated with a lower risk of myocardial infarction, stroke or cardiovascular death. The study, led by researchers from Karolinska Institutet in Sweden, is published in The Lancet Diabetes & Endocrinology.The number of patients with type 2 diabetes is increasing rapidly in the world. Cardiovascular disease is a serious complication of diabetes and represents a major cause of mortality in this patient group. Liraglutide, a diabetes medication, became

What will a Winter Storm Reality Check Reveal about Your Preparedness?

PCI Says Be Ready CHICAGO – With winter storms causing more than $1 billion in insured losses each year, the Property Casualty Insurers Association of America (PCI) urges property owners to take a winter storm preparedness reality check to ensure they are ready. “While winter storms can be very dangerous and cause significant damage  for drivers and homeowners, by taking a few simple steps you can ensure you’re ready for the next Arctic blast or storm system,” said Chris Hackett,

ShaMaran Announces Change of Director

VANCOUVER, BRITISH COLUMBIA, Dec. 5, 2018 /CNW/ - ShaMaran Petroleum Corp. ("ShaMaran" or the "Company") (TSX VENTURE: SNM) (Nasdaq Stockholm: SNM) is pleased to announce the appointment of Mike Ebsary to ShaMaran’s Board of Directors (“the Board”). The appointment is effective January 1, 2019. Mr. Ebsary will replace Mr. Ashley Heppenstall who has resigned from the Board with effect from December 31, 2018 to conform with industry corporate governance recommendations regarding the maximum number of non-executive director appointments per individual. Mr. Ebsary was previously the Chief

Convening Notice for an Extraordinary General Meeting of Shareholders

MILLICOM INTERNATIONAL CELLULAR S.A. société anonyme Registered Office: 2, Rue du Fort Bourbon L-1249 Luxembourg, Grand-Duchy of Luxembourg – R.C.S. Luxembourg: B 40.630 – I.NOTICE An extraordinary general meeting (“EGM”) of the shareholders of MILLICOM INTERNATIONAL CELLULAR S.A. (“Millicom” or the “Company”) is hereby convened to be held at the Millicom Registered Office, on Monday, January 7, 2019 at 12:00 noon Central European Time ("CET"). To attend the EGM or vote by proxy, please follow the instructions in the section IV: “Right to participate at the EGM”. (

Indigo Partners and WOW air Discussions Progressing

Reykjavik, Iceland – December 5, 2018 Indigo Partners (“Indigo”) and WOW air (“WOW”) initiated diligence meetings this week in Reykjavik as the initial steps to a potential Indigo investment after the signing a term sheet last week. A team from Indigo Partners spent the last two days with WOW air management to review the business and opportunities of the airline going forward. The overall process is progressing and both parties are working to finalize the investment. Issues remaining include WOW’s planned network development, vendor contracts including aircraft leases and certain

There are no items matching the current filter
There are no more items matching the current filter
Back to top